Companies / NovaBridge Biosciences

NovaBridge Biosciences

Nasdaq: NBPCIK 1778016ROCKVILLE, MD

Financials · FY2023

Revenue$3.89M
Net income$-88.34M
Total debt$4.22M
Cash$210.63M
Diluted EPS$-0.21
Shares outstanding265.4M

Ownership

265.4M shares outstanding
11.9%Institutions
Ownership
Institutions11.87%31,505,475
Public float88.13%233,872,416

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 16

View all →
Insider% of sharesShares
Cao Sean WuxiongSee Remarks · Director
Dennis Phillip AndrewChief Medical Officer
Fu WeiDirector
Fu Xi-YongSee Remarks · Director
Lei Ming KylerChief Financial Officer
Lin Liwei LorraineGeneral Counsel

Institutional holders 61

View all →
HolderValue% of shares
Hhlr Advisors, Ltd.$23.80M2.25%
Morgan Stanley$15.07M1.43%
Janus Henderson Group PLC$14.81M2.27%
Siren, L.L.C.$11.94M1.13%
Point72 Asset Management, L.P.$9.15M0.87%
Ariose Capital Management Ltd$5.43M0.51%
Candriam S.C.A.$4.51M0.43%
Woodline Partners LP$4.18M0.40%
Millennium Management LLC$3.37M0.32%
Barclays PLC$2.50M0.24%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NBPADREquity44975P103BBG00QQ8DFK6